483 Intas Pharmaceuticals Jun 2016

483 Intas Pharmaceuticals Jun 2016

Lucila Nwatu FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 17 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jun 2016
  • Location: Ahmedabad, India
  • FEI: 3003157498
Add To Cart